Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery

Authors: Pinheiro, A.C.; Mendonça, T.C.M.; De Souza, M.V.N.


Abstract

Heterocyclic compounds are a class of substances, which play a critical role in modern drug discovery being incorporated in the structure of a large variety of drugs used in many different types of diseases. Quinoxaline is an important heterocyclic nucleus with a wide spectrum of biological activities, and recently much attention has been found on anticancer drug discovery based on this class. Owing to the importance of this system, the aim of this review is to provide an update on the synthesis and anticancer activity of quinoxaline derivatives covering articles published between 2010 and 2015.


Keywords: Cancer, drug discovery, synthesis, quinoxaline, heterocyclic compounds, biological activity Document Type: Research Article DOI: 10.2174/1871520616666160622090839 Publication date: 1 de Janeiro de 2016 [:en]

Abstract

Heterocyclic compounds are a class of substances, which play a critical role in modern drug discovery being incorporated in the structure of a large variety of drugs used in many different types of diseases. Quinoxaline is an important heterocyclic nucleus with a wide spectrum of biological activities, and recently much attention has been found on anticancer drug discovery based on this class. Owing to the importance of this system, the aim of this review is to provide an update on the synthesis and anticancer activity of quinoxaline derivatives covering articles published between 2010 and 2015.


Keywords: Cancer, drug discovery, synthesis, quinoxaline, heterocyclic compounds, biological activity Document Type: Research Article DOI: 10.2174/1871520616666160622090839 Publication date: 1 de Janeiro de 2016 [:]

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes